Is Dapoxetine Available in the US?

No. Dapoxetine is not FDA-approved and is not commercially available as an approved prescription medication in the United States.

Dapoxetine (brand name Priligy in many countries) is a short-acting SSRI (selective serotonin reuptake inhibitor) specifically developed for the treatment of premature ejaculation (PE). It has been approved in many countries, including numerous European and Asian markets, but it has not received approval from the U.S. Food and Drug Administration (FDA) for the treatment of premature ejaculation.

Dapoxetine (Priligy and other brand names) has been approved for premature ejaculation treatment in dozens of countries, including European Union member states, China, Russia, Turkey, Mexico, Brazil, Argentina, Chile, Indonesia, and others. However, countries such as the United States, Canada, Australia, and Japan have not approved dapoxetine for the treatment of premature ejaculation.

Major Approved Regions and Timeline

Europe

Starting in 2009, dapoxetine was approved in several European countries, including:

• Sweden

• Finland

• Norway

• Germany

• Spain

• Italy

• Portugal

• Austria

Approval was obtained through centralized or mutual recognition procedures, allowing the medication to become available across most European Union countries.

Asia

• China approved the imported original dapoxetine product in 2010, and later several domestic generic versions were approved.

• Indonesia approved its first generic version in March 2026.

Latin America and Other Regions

Dapoxetine has also been approved and marketed in:

• Russia

• Turkey

• Mexico

• Brazil

• Argentina

• Chile

Countries Where It Has Not Been Approved

• United States: The FDA has not approved dapoxetine for premature ejaculation. The original application failed in 2004, and no PE indication approval has been granted to date.

• Canada, Australia, and Japan: These countries have also not approved dapoxetine for premature ejaculation treatment.

Dapoxetine is the first and for a long time the only oral SSRI medication specifically approved for on-demand treatment of premature ejaculation worldwide, but its regulatory approval remains highly regional.

“Approved” means that the medication has received official marketing authorization for the premature ejaculation indication. Some countries may allow off-label use of similar medications, but this does not mean the drug is officially approved for PE treatment.

The availability status of dapoxetine may change over time. For the latest information, regulatory databases such as the European Medicines Agency (EMA), China’s National Medical Products Administration (NMPA), and Indonesia’s BPOM should be consulted.

What Is Dapoxetine Used For?

Dapoxetine is primarily used for the treatment of male premature ejaculation (PE). It can help men delay ejaculation, improve control over ejaculation, and extend sexual activity time. It is generally intended for adult men aged 18 to 64 years who experience distress or difficulty due to premature ejaculation.

Simply put, dapoxetine is not an aphrodisiac or an erectile dysfunction medication. Instead, it is a medication specifically designed to address the problem of ejaculating too quickly and can help reduce psychological stress associated with premature ejaculation.

How Does Dapoxetine Work?

1. Regulating Nerve Signals

Dapoxetine works by increasing levels of a neurotransmitter called serotonin (5-hydroxytryptamine) in the brain. This helps improve the nervous system’s control over ejaculation and delays the transmission of ejaculation signals.

2. Fast Onset and Rapid Elimination

After taking dapoxetine:

• Blood concentration usually reaches its peak in approximately 1–3 hours.

• Its rapid absorption allows it to work around the planned time of sexual activity.

• It is metabolized and eliminated relatively quickly, reducing long-term accumulation in the body.

3. On-Demand Use

Unlike traditional SSRIs that are often taken daily, dapoxetine is designed for as-needed use.

Men typically take it before planned sexual activity rather than using it continuously, which may reduce long-term medication exposure.

Who May Benefit From Dapoxetine?

1. Men With Premature Ejaculation

Dapoxetine may be suitable for men diagnosed with:

• Lifelong premature ejaculation (primary PE) — ejaculation has occurred too quickly since the beginning of sexual activity.

• Acquired premature ejaculation (secondary PE) — ejaculation becomes faster later in life due to various factors.

2. Men Who Have Difficulty Controlling Ejaculation

Common symptoms include:

• Ejaculation occurring before or shortly after penetration.

• Difficulty delaying ejaculation despite attempts to control it.

• Inability to achieve satisfactory sexual duration.

3. Men Experiencing Emotional or Relationship Impact

Dapoxetine may be considered when premature ejaculation:

• Causes personal distress.

• Reduces sexual confidence.

• Negatively affects intimacy or relationships with a partner.